Stereoselective behavior of a novel biodegradable racemic ketoprofen injectable implant in rats.

Chirality

College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang 310031, People's Republic of China.

Published: November 2007

The stereoselectivity of release of ketoprofen (KET) enantiomers from a biodegradable injectable implant containing racemic KET (rac-KET) was investigated in vivo. A pre-column chiral derivatization RP-HPLC method was employed to assay diastereoisomeric derivatives of R- and S-KET. The rac-KET injectable implant, once injected subcutaneously in rats, produced long-lasting plasma levels of S-KET, which were always greater than those of R-KET. The difference in enantiomer concentration was to be related to stereoselective release, due to stereoselective interaction between D,L-PLG in the implant and KET enantiomers, as well as the chiral inversion of KET in vivo. The rac-KET injectable implant provided the sustained release of S-KET with effective plasma levels maintained for about 8 wk after a single injection.

Download full-text PDF

Source
http://dx.doi.org/10.1002/chir.20453DOI Listing

Publication Analysis

Top Keywords

injectable implant
16
ket enantiomers
8
rac-ket injectable
8
plasma levels
8
implant
5
stereoselective behavior
4
behavior novel
4
novel biodegradable
4
biodegradable racemic
4
racemic ketoprofen
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!